Apr 20, 2021
U.S. FDA Renews Licenses of DILIsym Software
Apr 12, 2021
Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results
Apr 07, 2021
Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company
Mar 29, 2021
Simulations Plus Sets Date for Second Quarter Fiscal Year 2021 Earnings Release and Conference Call
Mar 16, 2021
Simulations Plus Forms Scientific Advisory Board for RENAsym Consortium
Mar 11, 2021
Simulations Plus Hosts the Inaugural 2021 MIDD+ Scientific Conference with over 50 Model-Informed Drug Development Sessions
Mar 09, 2021
Simulations Plus to Present at Oppenheimer Healthcare Conference
Feb 23, 2021
Simulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety Collaboration